Different responses of PC12 cells to different pro-nerve growth factor protein variants

Marzia Soligo, Martina Albini, Federico Lorenzo Bertoli, Valeria Marzano, Virginia Protto, Luisa Bracci-Laudiero, Gaetana Minnone, Fabrizio De Benedetti, Antonio Chiaretti, Elide Mantuano, Luigi Manni

Research output: Contribution to journalArticle

Abstract

The present work aimed to explore the innovative hypothesis that different transcript/protein variants of a pro-neurotrophin may generate different biological outcomes in a cellular system. Nerve growth factor (NGF) is important in the development and progression of neurodegenerative and cancer conditions. Mature NGF (mNGF) originates from a precursor, proNGF, produced in mouse in two major variants, proNGF-A and proNGF-B. Different receptors bind mNGF and proNGF, generating neurotrophic or neurotoxic outcomes. It is known that dysregulation in the proNGF/mNGF ratio and in NGF-receptors expression affects brain homeostasis. To date, however, the specific roles of the two major proNGF variants remain unexplored. Here we attempted a first characterization of the possible differential effects of proNGF-A and proNGF-B on viability, differentiation and endogenous ngf gene expression in the PC12 cell line. We also investigated the differential involvement of NGF receptors in the actions of proNGF. We found that native mouse mNGF, proNGF-A and proNGF-B elicited different effects on PC12 cell survival and differentiation. Only mNGF and proNGF-A promoted neurotrophic responses when all NGF receptors are exposed at the cell surface. Tropomyosine receptor kinase A (TrkA) blockade inhibited cell differentiation, regardless of which NGF was added to culture media. Only proNGF-A exerted a pro-survival effect when TrkA was inhibited. Conversely, proNGF-B exerted differentiative effects when the p75 neurotrophin receptor (p75NTR) was antagonized. Stimulation with NGF variants differentially regulated the autocrine production of distinct proNgf mRNA. Overall, our findings suggest that mNGF and proNGF-A may elicit similar neurotrophic effects, not necessarily linked to activation of the same NGF-receptor, while the action of proNGF-B may be determined by the NGF-receptors balance. Thus, the proposed involvement of proNGF/NGF on the development and progression of neurodegenerative and tumor conditions may depend on the NGF-receptors balance, on specific NGF trancript expression and on the proNGF protein variant ratio.

Original languageEnglish
Pages (from-to)104498
JournalNeurochemistry International
DOIs
Publication statusE-pub ahead of print - Jul 3 2019

Fingerprint

Nerve Growth Factor
Nerve Growth Factor Receptors
Proteins
Nerve Growth Factor Receptor
Phosphotransferases
Nerve Growth Factors
Culture Media
Cell Differentiation
Neoplasms
Homeostasis
Gene Expression
Messenger RNA

Cite this

Different responses of PC12 cells to different pro-nerve growth factor protein variants. / Soligo, Marzia; Albini, Martina; Bertoli, Federico Lorenzo; Marzano, Valeria; Protto, Virginia; Bracci-Laudiero, Luisa; Minnone, Gaetana; De Benedetti, Fabrizio; Chiaretti, Antonio; Mantuano, Elide; Manni, Luigi.

In: Neurochemistry International, 03.07.2019, p. 104498.

Research output: Contribution to journalArticle

Soligo, Marzia ; Albini, Martina ; Bertoli, Federico Lorenzo ; Marzano, Valeria ; Protto, Virginia ; Bracci-Laudiero, Luisa ; Minnone, Gaetana ; De Benedetti, Fabrizio ; Chiaretti, Antonio ; Mantuano, Elide ; Manni, Luigi. / Different responses of PC12 cells to different pro-nerve growth factor protein variants. In: Neurochemistry International. 2019 ; pp. 104498.
@article{3d53d008164244f38044a74a21b2808f,
title = "Different responses of PC12 cells to different pro-nerve growth factor protein variants",
abstract = "The present work aimed to explore the innovative hypothesis that different transcript/protein variants of a pro-neurotrophin may generate different biological outcomes in a cellular system. Nerve growth factor (NGF) is important in the development and progression of neurodegenerative and cancer conditions. Mature NGF (mNGF) originates from a precursor, proNGF, produced in mouse in two major variants, proNGF-A and proNGF-B. Different receptors bind mNGF and proNGF, generating neurotrophic or neurotoxic outcomes. It is known that dysregulation in the proNGF/mNGF ratio and in NGF-receptors expression affects brain homeostasis. To date, however, the specific roles of the two major proNGF variants remain unexplored. Here we attempted a first characterization of the possible differential effects of proNGF-A and proNGF-B on viability, differentiation and endogenous ngf gene expression in the PC12 cell line. We also investigated the differential involvement of NGF receptors in the actions of proNGF. We found that native mouse mNGF, proNGF-A and proNGF-B elicited different effects on PC12 cell survival and differentiation. Only mNGF and proNGF-A promoted neurotrophic responses when all NGF receptors are exposed at the cell surface. Tropomyosine receptor kinase A (TrkA) blockade inhibited cell differentiation, regardless of which NGF was added to culture media. Only proNGF-A exerted a pro-survival effect when TrkA was inhibited. Conversely, proNGF-B exerted differentiative effects when the p75 neurotrophin receptor (p75NTR) was antagonized. Stimulation with NGF variants differentially regulated the autocrine production of distinct proNgf mRNA. Overall, our findings suggest that mNGF and proNGF-A may elicit similar neurotrophic effects, not necessarily linked to activation of the same NGF-receptor, while the action of proNGF-B may be determined by the NGF-receptors balance. Thus, the proposed involvement of proNGF/NGF on the development and progression of neurodegenerative and tumor conditions may depend on the NGF-receptors balance, on specific NGF trancript expression and on the proNGF protein variant ratio.",
author = "Marzia Soligo and Martina Albini and Bertoli, {Federico Lorenzo} and Valeria Marzano and Virginia Protto and Luisa Bracci-Laudiero and Gaetana Minnone and {De Benedetti}, Fabrizio and Antonio Chiaretti and Elide Mantuano and Luigi Manni",
note = "Copyright {\circledC} 2019. Published by Elsevier Ltd.",
year = "2019",
month = "7",
day = "3",
doi = "10.1016/j.neuint.2019.104498",
language = "English",
pages = "104498",
journal = "Neurochemistry International",
issn = "0197-0186",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Different responses of PC12 cells to different pro-nerve growth factor protein variants

AU - Soligo, Marzia

AU - Albini, Martina

AU - Bertoli, Federico Lorenzo

AU - Marzano, Valeria

AU - Protto, Virginia

AU - Bracci-Laudiero, Luisa

AU - Minnone, Gaetana

AU - De Benedetti, Fabrizio

AU - Chiaretti, Antonio

AU - Mantuano, Elide

AU - Manni, Luigi

N1 - Copyright © 2019. Published by Elsevier Ltd.

PY - 2019/7/3

Y1 - 2019/7/3

N2 - The present work aimed to explore the innovative hypothesis that different transcript/protein variants of a pro-neurotrophin may generate different biological outcomes in a cellular system. Nerve growth factor (NGF) is important in the development and progression of neurodegenerative and cancer conditions. Mature NGF (mNGF) originates from a precursor, proNGF, produced in mouse in two major variants, proNGF-A and proNGF-B. Different receptors bind mNGF and proNGF, generating neurotrophic or neurotoxic outcomes. It is known that dysregulation in the proNGF/mNGF ratio and in NGF-receptors expression affects brain homeostasis. To date, however, the specific roles of the two major proNGF variants remain unexplored. Here we attempted a first characterization of the possible differential effects of proNGF-A and proNGF-B on viability, differentiation and endogenous ngf gene expression in the PC12 cell line. We also investigated the differential involvement of NGF receptors in the actions of proNGF. We found that native mouse mNGF, proNGF-A and proNGF-B elicited different effects on PC12 cell survival and differentiation. Only mNGF and proNGF-A promoted neurotrophic responses when all NGF receptors are exposed at the cell surface. Tropomyosine receptor kinase A (TrkA) blockade inhibited cell differentiation, regardless of which NGF was added to culture media. Only proNGF-A exerted a pro-survival effect when TrkA was inhibited. Conversely, proNGF-B exerted differentiative effects when the p75 neurotrophin receptor (p75NTR) was antagonized. Stimulation with NGF variants differentially regulated the autocrine production of distinct proNgf mRNA. Overall, our findings suggest that mNGF and proNGF-A may elicit similar neurotrophic effects, not necessarily linked to activation of the same NGF-receptor, while the action of proNGF-B may be determined by the NGF-receptors balance. Thus, the proposed involvement of proNGF/NGF on the development and progression of neurodegenerative and tumor conditions may depend on the NGF-receptors balance, on specific NGF trancript expression and on the proNGF protein variant ratio.

AB - The present work aimed to explore the innovative hypothesis that different transcript/protein variants of a pro-neurotrophin may generate different biological outcomes in a cellular system. Nerve growth factor (NGF) is important in the development and progression of neurodegenerative and cancer conditions. Mature NGF (mNGF) originates from a precursor, proNGF, produced in mouse in two major variants, proNGF-A and proNGF-B. Different receptors bind mNGF and proNGF, generating neurotrophic or neurotoxic outcomes. It is known that dysregulation in the proNGF/mNGF ratio and in NGF-receptors expression affects brain homeostasis. To date, however, the specific roles of the two major proNGF variants remain unexplored. Here we attempted a first characterization of the possible differential effects of proNGF-A and proNGF-B on viability, differentiation and endogenous ngf gene expression in the PC12 cell line. We also investigated the differential involvement of NGF receptors in the actions of proNGF. We found that native mouse mNGF, proNGF-A and proNGF-B elicited different effects on PC12 cell survival and differentiation. Only mNGF and proNGF-A promoted neurotrophic responses when all NGF receptors are exposed at the cell surface. Tropomyosine receptor kinase A (TrkA) blockade inhibited cell differentiation, regardless of which NGF was added to culture media. Only proNGF-A exerted a pro-survival effect when TrkA was inhibited. Conversely, proNGF-B exerted differentiative effects when the p75 neurotrophin receptor (p75NTR) was antagonized. Stimulation with NGF variants differentially regulated the autocrine production of distinct proNgf mRNA. Overall, our findings suggest that mNGF and proNGF-A may elicit similar neurotrophic effects, not necessarily linked to activation of the same NGF-receptor, while the action of proNGF-B may be determined by the NGF-receptors balance. Thus, the proposed involvement of proNGF/NGF on the development and progression of neurodegenerative and tumor conditions may depend on the NGF-receptors balance, on specific NGF trancript expression and on the proNGF protein variant ratio.

U2 - 10.1016/j.neuint.2019.104498

DO - 10.1016/j.neuint.2019.104498

M3 - Article

C2 - 31278975

SP - 104498

JO - Neurochemistry International

JF - Neurochemistry International

SN - 0197-0186

ER -